雷姆迪西维尔:COVID-19中的一篇评论
1Springer Nature, Private Bag 65901, Mairangi Bay, Auckland, 0754, New Zealand. demail@springer.com.
Drugs
|August 17, 2023
概括
雷梅西维尔 (Veklury®) 是一种有效的COVID-19治疗方法,可显著减少住院患者的康复时间. 虽然通常是安全的,但现实世界的数据表明潜在的肝脏,脏和心血管风险.
科学领域:
- 药理学 药理学是指药理学的学科.
- 病毒学 病毒学
- 传染性疾病 传染性疾病
背景情况:
- 雷梅西维尔 (Veklury®) 是一种已批准用于治疗COVID-19的抗病毒药物.
- 它是一种核酸模拟前药物,具有针对SARS-CoV-2的广泛抗病毒活性.
- 与其他抗病毒药物相比,雷梅西维尔对药物相互作用的潜力较低.
研究的目的:
- 为了评估remdesivir在各种COVID-19患者群体中的疗效和安全性.
- 评估雷梅西维尔对康复时间,死亡率和不良事件的影响.
主要方法:
- 从关键ACTT-1试验和随后的临床试验中分析数据.
- 包括住院和门诊患者,包括儿科患者.
- 对药监数据的审查,以获得现实世界的安全洞察力.
主要成果:
- 在ACTT-1试验中,remdesivir显著减少了住院COVID-19患者康复的时间.
- 在基线需要最小氧气的患者中观察到更大的益处.
- 现实世界的数据表明肝脏,脏和心血管不良事件的风险增加.
结论:
- 雷梅西维尔是COVID-19的有价值的治疗选择,特别是对于需要补充氧气的患者.
- 虽然有效地加速恢复,但需要仔细监测药物不良反应.
- 进一步的研究可能会澄清其在特定患者子组和死亡率益处中的作用.
更多相关视频
08:36Author Spotlight: Evaluating the Adjuvant Efficacy and Safety of Angong Niuhuang Pill in Viral Encephalitis Treatment
Published on: April 19, 2024
585
10:29Quantitative Structure-Activity Relationship, Activity Prediction, and Molecular Dynamics of Non-nucleotide Reverse Transcriptase Inhibitors
Published on: May 9, 2025
1.2K
相关概念视频
Subviral Agents
41
Subviral agents are infectious entities that resemble viruses but lack one or more viral components, such as a capsid or essential replication machinery. These agents include viroids, prions, and satellites, each possessing distinct structural and functional characteristics that influence their mode of infection and replication.Viroids are the simplest subviral agents, consisting of circular, single-stranded RNA molecules without a protein coat. They exclusively infect plants, relying entirely...
41
Antimicrobial Effectiveness
48
The effectiveness of antimicrobial agents depends on various factors influencing their ability to eliminate microbial populations. Larger microbial populations require more time for complete eradication, emphasizing the importance of population size analysis when evaluating antimicrobial efficacy.Microbial resistance to antimicrobial agents varies significantly. Highly resilient microorganisms include endospores, gram-negative bacteria, and non-enveloped viruses, while prions are exceptionally...
48
Pharmacovigilance
889
Post-marketing surveillance is a critical component of pharmaceutical regulation, often uncovering unanticipated adverse drug reactions (ADRs) once a drug is widely used over an extended period.
This process, termed pharmacovigilance, aims to detect, evaluate, and minimize harmful effects related to medication use. The data collection for pharmacovigilance depends on spontaneous reporting systems, where healthcare professionals or patients voluntarily report suspected ADRs.
In some cases, there...
This process, termed pharmacovigilance, aims to detect, evaluate, and minimize harmful effects related to medication use. The data collection for pharmacovigilance depends on spontaneous reporting systems, where healthcare professionals or patients voluntarily report suspected ADRs.
In some cases, there...
889
Myocarditis III: Medical Management
9
Myocarditis: Comprehensive Medical ManagementMyocarditis, the heart muscle inflammation, requires a comprehensive medical management strategy that addresses the underlying cause, provides supportive care, manages symptoms, and reduces cardiac workload.Infections and Autoimmune CausesAdminister appropriate antimicrobial therapy when an infectious agent causes myocarditis. For instance, penicillin treats infections caused by Group A Streptococcus. In cases where autoimmune processes are...
9
Peripherally and Centrally Acting Muscle Relaxants: A Comparison
3.4K
Skeletal muscle relaxants can target the central nervous system [CNS] to reduce muscle tension or act directly at the neuromuscular junction to induce temporary paralysis. These two classes of muscle relaxants are called centrally acting muscle relaxants and peripherally acting muscle relaxants. They differ in their action, mechanism, administration route, and clinical uses.
Centrally acting muscle relaxants can be further divided into spasmolytic and antispasmodic drugs. Spasmolytic...
Centrally acting muscle relaxants can be further divided into spasmolytic and antispasmodic drugs. Spasmolytic...
3.4K
Pericarditis III: Medical Management
14
The primary objectives of managing pericarditis are to determine the underlying cause, provide effective therapy for treatment and symptom relief, and promptly detect signs and symptoms of cardiac tamponade. The following outlines the essential aspects of medical management for pericarditis:ObjectivesDetermine the Cause: Identifying the underlying cause of pericarditis is crucial for targeted treatment. Causes include viral infections, autoimmune diseases, post-cardiac injury syndrome, and...
14
